The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders

Research output: Contribution to journal › Comment/Letter to the editor › Academic

5 Citations (Scopus)

Original language	English
Pages (from-to)	46-48
Number of pages	3
Journal	European neuropsychopharmacology
Volume	62
DOIs	https://doi.org/10.1016/j.euroneuro.2022.07.003
Publication status	Published - Sept 2022
Externally published	Yes

Access to Document

@article{01925589045f4cc3b7dfc97161f1ef20,

title = "The future of antipsychotics studies: How innovative designs may benefit patients with psychotic disorders",

author = "Luykx, {Jurjen J.}",

year = "2022",

month = sep,

doi = "10.1016/j.euroneuro.2022.07.003",

language = "English",

volume = "62",

pages = "46--48",

journal = "European neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

}

TY - JOUR

T1 - The future of antipsychotics studies

T2 - How innovative designs may benefit patients with psychotic disorders

AU - Luykx, Jurjen J.

PY - 2022/9

Y1 - 2022/9

UR - http://www.scopus.com/inward/record.url?scp=85134976043&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2022.07.003

DO - 10.1016/j.euroneuro.2022.07.003

M3 - Comment/Letter to the editor

C2 - 35896056

SN - 0924-977X

VL - 62

SP - 46

EP - 48

JO - European neuropsychopharmacology

JF - European neuropsychopharmacology

ER -